JPRN-jRCT1080220598未知4 期
Post marketing clinical trial of TJ-54 for patients who have neuropsychiatric symptoms of Parkinson`s disease
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •1.Patients with NPI subscale score of 4 points or greater on more than one subscale 4 weeks prior to and at the start of treatment
- •2.Patients with MMSE (Mini-Mental State Examination) score of 24 points or greater 4 weeks prior to and at the start of treatment
排除标准
- •1.Patients who are diagnosed with dementia based on DSM-IV criteria [Diagnostics and Statistical Manual of Mental Disorders, 4th Edition]
- •2.Patients with serious complications(heart, liver, or kidney dysfunctions, hematopoietic disorders, malignant tumors, etc.) and other life-threatening diseases.
研究者
相似试验
招募中
1 期
Dermal Safety Study of JTE-052atopic dermatitisJPRN-jRCT2031230570Koretomo Ryosuke22
招募中
1 期
Clinical trial of subsequent injection of HVJ-E to those patients who enrolled in the clinical trial of ' Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E to castration resistant prostate cancer patients 'castration resistant prostate cancerJPRN-UMIN000010840Department of Urology, Osaka University Graduate School of Medicine9
未知
2 期
Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis.JPRN-jRCT2080220803JAPAN TABACCO INC.320
尚未招募
2 期
Investigation on efficacy and safety of TJ-50 for the patients with postoperative chronic sinusitisJPRN-UMIN000031689Yokohama city university medical center Otolaryngolgy40
招募中
不适用
Randomized phase II study of TJ-3020 in patients with unresectable advanced or recurrent pancreatic cancer receiving nab-Paclitaxel plus Gemcitabinepatients with unresectable advanced or recurrent pancreatic cancerJPRN-UMIN000027631agoya University56